Skip to main content

Table 4 BRCA1 and BRCA2 germline pathogenic mutations identified using NGS and MLPA in a South African cohort divided according to premenopausal diagnosis, triple negative status and ethnicity

From: BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer

Total n = 108

Dx < 50 n = 92 (85.2 %)

Dx > 50 n = 16 (14.8 %)

Total no. of mutations per ethnic group

TNBC n = 14 (13.0 %)

Not TNBC n = 78 (72.2 %)

TNBC

Black n = 85 (78.7 %)

n = 7

n = 70

n = 8

6 (7.1 %)

Mutations

BRCA1

BRCA2

BRCA1

BRCA2

BRCA1

BRCA2

 
 

c.212G > A

-

c.1155G > A

c.582G > A

-

c.5771_5774delTTCA

 

-

-

c.1953_1954insA

c.9097_9098insA

-

-

White n = 16 (14.8 %)

n = 4

n = 5

n = 7

5 (31.3 %)

Mutations

BRCA1

BRCA2

BRCA1

BRCA2

BRCA1

BRCA2

 
 

c.181 T > G

c.7934delG

-

c.7934delG

Exon 1a-2 del

-

 

-

-

-

c.5213_5216delCTTA

-

-

Indian n = 5 (4.6 %)

n = 2

n = 2

n = 1

2 (40.0 %)

Mutations

BRCA1

BRCA2

BRCA1

BRCA2

BRCA1

BRCA2

 
 

c.3593 T > A

c.8754 + 1G > A

-

-

-

-

Coloured n = 2 (1.9 %)

n = 1

n = 1

0

0

Mutations

-

-

-

Total mutations per subgroup

5 (35.7 %)

6 (7.7 %)

2 (12.5 %)

Â